ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025
Correction: Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.
Eric S Christenson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.